Yesterday's Wall Street Journal included a feature article on the comeback of technology IPOs. (Thank goodness. We needed the refresher course after almost forgetting what "IPO" stood for.)
IPOs seem to be making a comeback in this field as well. Rosetta Genomics recently raised more than $25 million in its first offering, and Helicos BioSciences filed for an IPO of its own at the end of February.